The second edition comprehensively reviews the wide field of rare pulmonary diseases. Issues such as less common diseases affecting the airways, systematic disorders with lung involvement, interstitial lung diseases, and many other orphan conditions of the lungs are explored in this book. The progress and advances made in the field and the limited number of patients presenting each condition makes it very difficult for clinicians to be up-to-date in this field. Readers will discover how to diagnose and manage these rare orphan diseases. Orphan Lung Diseases: A Clinical Guide to Rare Lung Disease is a practical, informative book written by a team of international authors with much experience in rare pulmonary diseases
Orphan Lung Diseases: A Clinical Guide to Rare Lung Disease, second edition provides synthesized and easily accessible information about the main orphan lung diseases, to aid clinicians in charge of patients with rare disease, or who consider the diagnosis of a rare disease in their patient. It is a practical, informative guide written by a team of international experienced authors in rare pulmonary diseases.
About the Author: Prof Vincent Cottin is coordinator of the national reference center for rare pulmonary diseases in France, with a 21 years experience in rare pulmonary diseases. He has coordinated the first edition of this book, together with Prof L. Richeldi (and Prof JF. Cordier, now retired). He is current section editor for the Eur Respir J (impact factor > 12), and past editor in chief of the Eur Respir Review.
Prof Luca Richeldi is heading the interstitial lung disease clinic at the Gemelli hospital in Roma, Italy, and is an author of landmark publications in the field.
Prof Kevin Brown is director of the interstitial lung disease program at the National Jewish Medical and Research Center in Denver, Colorado, one of the main centers for research and education in this field.
Prof Frank M.X. McCormack is the principal investigator of the US Rare Lung Disease Network, and a expert in multiple cystic lung diseases and many other rare pulmonary diseases. All four editors are reknown leaders in the field of rare pulmonary diseases especially interstitial lung diseases, with a track record of original publication and review articles, as well as editorial experience.
